BioAdvance News

BioAdvance’s ROI Tops $11 Million

By WebmasterOctober 7, 2011November 1st, 2024No Comments

BioAdvance’s ROI Tops $11 Million
Read more here

Previous PostQR Pharma Reports Results from SBIR Grant by NIA/NIH to Study Posiphen® and Metabolites in Various Models
Next PostFDA Accepts Filing of New Drug Application (NDA) for Yaupon's Proprietary Gel Formulation of Mechlorethamine Hydrochloride